Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine

Immunotherapy
Mark O HardinGeorge E Peoples

Abstract

We developed a novel approach to efficiently deliver autologous tumor antigens to the cytoplasm of dendritic cells (DC) using yeast cell wall particles (YCWP). Loading of YCWP, leakage of protein from loaded YCWP and cytoplasmic delivery of YCWP content was assessed using fluorescent-tagged experiments. Spectrophotometric analysis compared the epitope-specific T-cell responses following antigen presentation via YCWP versus exogenous loading. The in vivo effectiveness of tumor lysate (TL) particle loaded DC (TLPLDC) vaccine was assessed using murine melanoma models. In fluorescence-tagged experiments, YCWP efficiently delivered antigen to the cytoplasm of DC. TLPLDC loading was more effective than conventional exogenous loading of DC. Finally, in murine melanoma models, TLPLDC outperformed an analogous dendritoma vaccine. The TLPLDC vaccine is commercially scalable and holds the potential of producing personalized vaccines.

References

Sep 3, 2004·The New England Journal of Medicine·Hensin TsaoArthur J Sober
May 21, 2009·Experimental and Molecular Pathology·Bennett JensonDonald M Miller
May 21, 2009·Experimental and Molecular Pathology·Jingjing LiuJun Yan
Apr 23, 2010·Seminars in Immunology·Pawel Kalinski, Hideho Okada
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Aug 10, 2010·Nanomedicine : Nanotechnology, Biology, and Medicine·Shashi PrasadDouglas J Hanlon
Aug 17, 2010·FEMS Yeast Research·Andressa ArdianiJames W Hodge
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Nov 26, 2010·Immunotherapy·Meghan E Turnis, Cliona M Rooney
Feb 15, 2011·American Journal of Therapeutics·Marijo Bilusic, Ravi A Madan
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Sep 2, 2011·Chemical Communications : Chem Comm·Sara FigueiredoEnzo Terreno
Oct 21, 2011·Journal of Drug Delivery·Ernesto R SotoGary R Ostroff
Mar 23, 2012·Nature Reviews. Cancer·Karolina Palucka, Jacques Banchereau
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Jul 31, 2013·Immunity·Karolina Palucka, Jacques Banchereau
Aug 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D McDermottUNKNOWN MDX010-20 Investigators
Oct 4, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick A OttCaroline Robert
Jan 11, 2014·Frontiers in Immunology·Jan FricPaola Ricciardi-Castagnoli
Jun 2, 2014·Hematology/oncology Clinics of North America·Jarushka NaidooJedd D Wolchok
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Erika J SchnebleGeorge E Peoples
Mar 12, 2016·Cell·A Karolina Palucka, Lisa M Coussens

❮ Previous
Next ❯

Citations

Nov 10, 2018·Anti-cancer Agents in Medicinal Chemistry·Hanjiao QinZhuo Zhang
Aug 18, 2021·Advanced Drug Delivery Reviews·Tong YeWei Wei
Jun 24, 2021·Expert Opinion on Drug Discovery·Monica Chanda, Mark S Cohen

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy

Software Mentioned

SPSS
SPSS Statistics

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.